More women CXOs join India’s million-dollar pay club as domestic firms lead compensation growthNine women now earn over one million dollars annually as C-suite executives. Domestic companies are leading this rise, reflecting a focus o...
01 Jun, 2026, 03.10 PM IST
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
24 May, 2026, 04.23 PM IST
Divi's Laboratories Q4 Results: Cons PAT grows 13% YoY to Rs 751 crore, revenue up 10%; Rs 30 per share dividend announcedDivi's Laboratories Q4 Results: Divi's Laboratories announced strong financial results for the March quarter. Net profit rose 13% to Rs 751...
23 May, 2026, 01.51 PM IST
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
20 May, 2026, 12.05 PM IST
Divi's Lab inks supply pact with global pharmaceutical entityDivi's Laboratories announced a long-term supply agreement with a global pharmaceutical company, focusing on manufacturing and supplying ad...
18 Apr, 2025, 01.06 PM IST
Share price of Divis Labs falls as Nifty weakensA total of 2,065 shares changed hands on the counter till 01:08PM (IST).
27 Sep, 2024, 01.08 PM IST
Divis Labs shares down 1.14% as Nifty gainsThe stock quoted a 52-week high price of Rs 5582.85 and low of Rs 3300.0.
26 Sep, 2024, 11.47 AM IST
Share price of Divis Labs jumps as Sensex gains 205.36 pointsA total of 3,236 shares changed hands on the counter till 11:06AM (IST)
23 Sep, 2024, 11.06 AM IST
Buy Divi's Laboratories, target price Rs 3742: ICICI DirectDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 98115.86 Crore) operating in Pharmace...
07 Sep, 2023, 11.11 AM IST
Divi's Labs shares drop 2% on brokerage downgrades post Q1 result. Should you buy, sell or hold?Divi's Laboratories on Monday saw a 49% year-on-year (YoY) fall in its consolidated net profit at Rs 356 crore for the quarter ended June 2...
16 Aug, 2023, 11.23 AM IST
Buy Divi's Laboratories, target price Rs 3762: ICICI DirectDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 99034.38 Crore) operating in Pharmace...
16 Aug, 2023, 10.26 AM IST
Divi's Labs Q1 Results: Profit nearly halves to Rs 356 crore on YoY basis, misses estimatesRevenue from operations during the first quarter dropped 21% to Rs 1,778 crore, compared with Rs 2,255 crore in the same quarter of last ye...
14 Aug, 2023, 01.42 PM IST
Buy Divi's Laboratories, target price Rs 4130: Religare BrokingPromoters held 51.93 per cent stake in the company as of 30-Jun-2023, while FIIs owned 14.69 per cent, DIIs 21.03 per cent.
08 Aug, 2023, 09.53 AM IST
Divi's Lab shares jump over 9% as exports rise in MarchThe consensus recommendation from 23 analysts for Divi's Lab is Sell. Out of these analysts, only six have strong buy and buy ratings, whil...
12 Apr, 2023, 02.44 PM IST
Divi's Labs shares fall 9% post Sept quarter numbers; here's whyWe envisage near term pressures growin for Divi's Labs, with rising raw material prices, logistical issues and declining generics business,...
08 Nov, 2021, 10.56 AM IST
India’s best-performing stock is seeing a wave of optimistic callsThe optimism is stemming from the company’s capacity-expansion plans and potential to win more business as India cuts its reliance on Chine...
13 Jan, 2021, 03.55 PM IST
- Buy Divi's Laboratories Ltd with a target of Rs 1520: Sandeep Wagle
"Divi's Laboratories Ltd is a 'BUY' call with a target of Rs 1520 and a stop loss of Rs 1402."
30 Jun, 2014, 09.42 AM IST